NewsRx

Search our medical news database

Hepatitis B Vaccine

Infection in kidney transplant patient caused by novel mutants of hepatitis B

Published in Vaccine Weekly, June 4th, 2003

An infection in a renal transplant recipient caused by novel mutants of hepatitis B virus occurred despite protective anti-hepatitis B surface antibodies.

"A renal transplant recipient became persistently positive for hepatitis B virus (HBV) despite pre-existing anti-hepatitis B surface (HBs) antibodies," researchers in Germany report.

"The antigenicity and immunogenicity of wild-type (wt) and mutant HBs antigens (Ags) were compared," stated Mengji G. Lu and Thomas Lorentz at the Universitatsklinikum Essen. "In contrast to wt HBsAg, genetic vaccination with mutant HBsAgs did not induce anti-HBs. Thus, mutations within HBsAg may enable HBV to escape...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook